These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders. Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603 [TBL] [Abstract][Full Text] [Related]
5. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype. Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333 [TBL] [Abstract][Full Text] [Related]
6. A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders. Gonzalez-Mantilla AJ; Moreno-De-Luca A; Ledbetter DH; Martin CL JAMA Psychiatry; 2016 Mar; 73(3):275-83. PubMed ID: 26817790 [TBL] [Abstract][Full Text] [Related]
7. Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism. Padhi EM; Hayeck TJ; Cheng Z; Chatterjee S; Mannion BJ; Byrska-Bishop M; Willems M; Pinson L; Redon S; Benech C; Uguen K; Audebert-Bellanger S; Le Marechal C; Férec C; Efthymiou S; Rahman F; Maqbool S; Maroofian R; Houlden H; Musunuri R; Narzisi G; Abhyankar A; Hunter RD; Akiyama J; Fries LE; Ng JK; Mehinovic E; Stong N; Allen AS; Dickel DE; Bernier RA; Gorkin DU; Pennacchio LA; Zody MC; Turner TN Hum Genomics; 2021 Jul; 15(1):44. PubMed ID: 34256850 [TBL] [Abstract][Full Text] [Related]
8. De novo and biallelic DEAF1 variants cause a phenotypic spectrum. Nabais Sá MJ; Jensik PJ; McGee SR; Parker MJ; Lahiri N; McNeil EP; Kroes HY; Hagerman RJ; Harrison RE; Montgomery T; Splitt M; Palmer EE; Sachdev RK; Mefford HC; Scott AA; Martinez-Agosto JA; Lorenz R; Orenstein N; Berg JN; Amiel J; Heron D; Keren B; Cobben JM; Menke LA; Marco EJ; Graham JM; Pierson TM; Karimiani EG; Maroofian R; Manzini MC; Cauley ES; Colombo R; Odent S; Dubourg C; Phornphutkul C; de Brouwer APM; de Vries BBA; Vulto-vanSilfhout AT Genet Med; 2019 Sep; 21(9):2059-2069. PubMed ID: 30923367 [TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation. Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157 [TBL] [Abstract][Full Text] [Related]
10. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779 [TBL] [Abstract][Full Text] [Related]
11. De novo variants in CNOT3 cause a variable neurodevelopmental disorder. Martin R; Splitt M; Genevieve D; Aten E; Collins A; de Bie CI; Faivre L; Foulds N; Giltay J; Ibitoye R; Joss S; Kennedy J; Kerr B; Kivuva E; Koopmans M; Newbury-Ecob R; Jean-Marçais N; Peeters EAJ; Smithson S; Tomkins S; Tranmauthem F; Piton A; van Haeringen A Eur J Hum Genet; 2019 Nov; 27(11):1677-1682. PubMed ID: 31201375 [TBL] [Abstract][Full Text] [Related]
12. Recurrent Tan NB; Pagnamenta AT; Ferla MP; Gadian J; Chung BH; Chan MC; Fung JL; Cook E; Guter S; Boschann F; Heinen A; Schallner J; Mignot C; Keren B; Whalen S; Sarret C; Mittag D; Demmer L; Stapleton R; Saida K; Matsumoto N; Miyake N; Sheffer R; Mor-Shaked H; Barnett CP; Byrne AB; Scott HS; Kraus A; Cappuccio G; Brunetti-Pierri N; Iorio R; Di Dato F; Pais LS; Yeung A; Tan TY; Taylor JC; Christodoulou J; White SM J Med Genet; 2022 May; 59(5):511-516. PubMed ID: 34183358 [TBL] [Abstract][Full Text] [Related]
13. Second-tier trio exome sequencing after negative solo clinical exome sequencing: an efficient strategy to increase diagnostic yield and decipher molecular bases in undiagnosed developmental disorders. Tran Mau-Them F; Moutton S; Racine C; Vitobello A; Bruel AL; Nambot S; Kushner SA; de Vrij FMS; Lehalle D; Jean-Marçais N; Lecoquierre F; Delanne J; Thevenon J; Poe C; Jouan T; Chevarin M; Geneviève D; Willems M; Coubes C; Houcinat N; Masurel-Paulet A; Mosca-Boidron AL; Tisserant E; Callier P; Sorlin A; Duffourd Y; Faivre L; Philippe C; Thauvin-Robinet C Hum Genet; 2020 Nov; 139(11):1381-1390. PubMed ID: 32399599 [TBL] [Abstract][Full Text] [Related]
14. Hubert L; Cannata Serio M; Villoing-Gaudé L; Boddaert N; Kaminska A; Rio M; Lyonnet S; Munnich A; Poirier K; Simons M; Besmond C J Med Genet; 2020 Feb; 57(2):138-144. PubMed ID: 31439720 [TBL] [Abstract][Full Text] [Related]
15. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome. Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258 [TBL] [Abstract][Full Text] [Related]
16. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing. Hiraide T; Yamoto K; Masunaga Y; Asahina M; Endoh Y; Ohkubo Y; Matsubayashi T; Tsurui S; Yamada H; Yanagi K; Nakashima M; Hirano K; Sugimura H; Fukuda T; Ogata T; Saitsu H Clin Genet; 2021 Jul; 100(1):40-50. PubMed ID: 33644862 [TBL] [Abstract][Full Text] [Related]
17. De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder. Yoon JG; Lim SK; Seo H; Lee S; Cho J; Kim SY; Koh HY; Poduri AH; Ramakumaran V; Vasudevan P; de Groot MJ; Ko JM; Han D; Chae JH; Lee CH Am J Hum Genet; 2024 Aug; 111(8):1588-1604. PubMed ID: 39047730 [TBL] [Abstract][Full Text] [Related]
18. De novo missense variants in ZBTB47 are associated with developmental delays, hypotonia, seizures, gait abnormalities, and variable movement abnormalities. Ward SK; Wadley A; Tsai CA; Benke PJ; Emrick L; Fisher K; Houck KM; Dai H; ; Guillen Sacoto MJ; Craigen W; Glaser K; Murdock DR; Rohena L; Diderich KEM; Bruggenwirth HT; Lee B; Bacino C; Burrage LC; Rosenfeld JA Am J Med Genet A; 2024 Jan; 194(1):17-30. PubMed ID: 37743782 [TBL] [Abstract][Full Text] [Related]
19. De novo variants in Bina R; Matalon D; Fregeau B; Tarsitano JJ; Aukrust I; Houge G; Bend R; Warren H; Stevenson RE; Stuurman KE; Barkovich AJ; Sherr EH J Med Genet; 2020 Jul; 57(7):461-465. PubMed ID: 31924697 [TBL] [Abstract][Full Text] [Related]
20. Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ; J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]